Remote ischemic preconditioning in patients undergoing cardiac surgery with six ischemic cycles.

ABSTRACT

BACKGROUND: We have previously shown that remote ischemic preconditioning (RIP), which utilizes in part the extracellular RNA (eRNA)/RNase1 pathway, can induce ischemic tolerance in humans. Because RIP has thus far been tested only with four cycles of extremity ischemia/reperfusion, we investigated the influence of six cycles of ischemia on the eRNA/RNase1 pathway in cardiac patients. METHODS: Six cycles of RIP were carried out in 14 patients undergoing cardiac surgery. Blood samples were taken at 13 timepoints during surgery and at three timepoints after surgery for determining serum levels of RNase1, eRNA, and TNF-α. Trans-cardiac gradients between the myocardial blood inflow and outflow were calculated. RESULTS: Between the fourth and the sixth RIP cycles, a noticeable increase in the levels of eRNA (fourth 151.6 (SD 44.2) ng/ml vs sixth 181.8 (SD 87.5) ng/ml, p = .071), and a significant increase in RNase1 (fourth 151.1 (SD 42.6) U/ml vs sixth 175.3 (SD 41.2) U/ml, p = .001), were noted. The trans-cardiac gradients of RNase1 and eRNA before and after ischemia were not significantly different (p = .158 and p = .221; p = .397 and p = .683, respectively). Likewise, the trans-cardiac gradient of TNF-α was similar before and after ischemia. During the first 48 h after the surgery, RNase1 activity rose significantly and exceeded baseline values (135.7 (SD 40.6) U/ml before and 279.2 (SD 85.6) U/ml after surgery, p = .001) as did eRNA levels (148,6 (SD 35.4) ng/ml before and 396.5 (SD 154.5) ng/ml after surgery, p = .005), whereas TNF-α levels decreased significantly (91.7 (SD 47.7) pg/ml before and 35.7 (SD 36.9) pg/ml after surgery, p = .001). CONCLUSION: Six RIP cycles increased the RNase1 levels significantly above those observed with four cycles. More clinical data are required to show whether this translates into a benefit for patients.